This paper is a response to Dr. Kathleen Raviele's recent article on her critical analysis of the use of levonorgestrel given to women postsexual assault and her suggestion that the use of Meloxicam may be an ethical alternative.
American Life League. 2005. My secret life. Stafford, VA: American Life League, Inc.
2.
BairdD.D., WeinbergC.R., McConnaugheyR., and WilcoxA.J.. 2002. Rescue of the corpus luteum in human pregnancy. Biology of Reproduction68: 448–56. doi: 10.1095/biolreprod.102.008425
3.
BanerjeeP., and FazleabasA.T.. 2010. Endometrial responses to embryonic signals in the primate. International Journal of Developmental Biology54: 295–302. doi: 10.1387/ijdb.082829pb
4.
BermasB.L.2014. Non-steroidal anti inflammatory drugs, glucocorticoids and disease modifying anti-rheumatic drugs for the management of rheumatoid arthritis before and during pregnancy. Current Opinion in Rheumatology26(3). 3: 334–40. doi: 10.1097/BOR.0000000000000054
5.
BriggsG., FreemanR., YaffeeS., and SumnerJ.. 2011. A Reference guide to fetal and neonatal risk. Drugs in pregnancy and lactation, 9th ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins.
6.
Catechism of the Catholic Church. 2nd ed. 1997. Vatican City: Liberia Editrice Vaticana.
7.
ChaJ., SunX., and DeyS.K.. 2012. Mechanisms of implantation: Strategies for successful pregnancy. Nature Medicine18: 1755–67. doi: 10.1038/nm.3012
CorreaA., GilboaS.M., BottoL.D., MooreC.A., HobbsC.A., ClevesM.A., Riehle-ColarussoT.J., WallerD.K., ReeceE.A., and the National Birth Defects Prevention Study. 2012. Lack of periconceptional vitamins or supplements that contain folic acid and diabetes mellitus-associated birth defects. American Journal of Obstetrics and Gynecology206: 218.e1–e13. doi: 10.1016/j.ajog.2011.12.018
10.
CreninM.D., SchlaffW., ArcherD.F., WanL., FrezieresR., ThomasM., RosenbergM., and HigginsJ.. 2006. Progesterone receptor modulator for emergency contraception: a randomized controlled trial. Obstetrics and Gynecology108: 1089–97. doi: 10.1097/01.AOG.0000239440.02284.45
11.
CroxattoH.B.2005. Progesterone receptors and opportunities for contraception. InNew mechanisms for tissue-selective estrogen-free contraception, eds. CroxattoH.B., SchurmannR., FuhrmannR.U., and SchellschmidtU., 1–17. I. Ernst Schering Research Foundation (Workshop 52). Berlin, Heidelburg: Springer-Verlag.
CroxattoH.B., BracheV., PavezM., CochonL., ForcelledoM.L., AlvarezF., MassaiR., FaundesA., and SalvatierraA.M.. 2004. Pituitary-ovarian function following the standard levonorgestrel emergency contraceptive dose of a single 0.75-mg dose given on the days preceding ovulation. Contraception70: 442–50. doi: 10.1016/j.contraception.2004.05.007
14.
CunninghamF.D., LevenoK.J., BloomS.L., HauthJ.C., RouseD.J., and SpongC.Y. (eds.). 2010. Williams obstetrics. 23rd ed. New York: McGraw Hill Medical.
15.
DavidoffF., and TrussellJ.. 2006. Plan B and the politics of doubt. Journal of the American Medical Association296: 1775–7. doi: 10.1001/jama.296.14.1775
16.
DaviesN.M., and SkjodtN.M.. 1999. Clinical pharmacokinetics of meloxicam: A cyclo-oxygenase-2 preferential nonsteroidal anti-inflammatory drug. Clinical Pharmacokinetics36: 115–26. doi: 10.2165/00003088-199936020-00003
17.
DelgadoG., and DavenportM.L.. 2012. Progesterone use to reverse the effects of mifepristone. Annals of Pharmacotherapy46: e36. doi: 10.1345/aph.1R252
18.
DorniakP., BazerF.W., and SpencerT.E.. 2011. Prostaglandins regulate conceptus elongation and mediate effects of interferon tau on the ovine uterine endometrium. Biology of Reproduction84: 1119–27. doi: 10.1095/biolreprod.110.089979
19.
DurandM., del Carmen CraviotoM., RaymondE.G., Duran-SanchezO., De la Luz Cruz-HinojosaM., Caell-RodriguezA., SchiavonR., and LareaF.. 2001. On the mechanisms of action of short-term levonorgestrel administration in emergency contraception. Contraception64: 227–34. doi: 10.1016/S0010-7824(01)00250-5
20.
EdwardsD.R., AldridgeT., BairdD.D., FunkM.J., SavitzD.A., and HartmannK.E.. 2012. Periconceptual over-the-counter nonsteroidal anti-inflammatory drug exposure and the risk for spontaneous abortion. Obstetrics and Gynecology120: 113–22. doi: 10.1097/AOG.0b013e3182595671
21.
ErdemH., and GuzelogluA.. 2008. Effect of meloxicam treatment during early pregnancy in Holstein Heifers. Reproduction in Domestic Animals45: 625–28.
22.
ErkkolaR., and LandgrenB.M.. 2005. Role of progestins in contraception. Acta Obstetricia et Gynecologica Scandinavica84: 207–16. doi: 10.1111/j.0001-6349.2005.00759.x
23.
GlasierA.1997. Emergency postcoital contraception. New England Journal of Medicine337: 1058–64. doi: 10.1056/NEJM199710093371507
24.
GlasierA., and ShieldsW.C.. 2006. Editorial: Can we improve contraceptive use?Contraception73: 1–3. doi: 10.1016/j.contraception.2005.09.004
25.
HamelR.2010. Thinking critically about emergency contraception. Critical judgments require adequate and accurate information. Health Progress91: 62–7.
26.
HammondH.A., RedmanJ.B., and CaskeyC.T.. 1995. In uteropaternity testing following alleged sexual assault. Journal of the American Medical Association273: 1774–7. doi: 10.1001/jama.1995.03520460056035
27.
HapangamaD., GlasierA., and BairdD.T.. 2001. The effects of peri-ovulatory administration of levonorgestrel on the menstrual cycle. Contraception63: 123–9. doi: 10.1016/S0010-7824(01)00186-X
28.
HernandezR.K., WerlerM.M., RomittiP., SunL., AnderkaM., and the National Birth Defects Prevention Study. 2012. American Journal of Obstetrics and Gynecology206: 228.e1–e8. doi: 10.1016/j.ajog.2011.10.522
29.
HoP.C., and KwanM.S.W.. 1993. A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in post-coital contraception. Human Reproduction8: 389–92.
30.
HolmesM.M., ResnickH.S., KilpatrickD.G., and BestC.L.. 1996. Rape-related pregnancy: Estimates and descriptive characteristics from a national sample of women. American Journal of Obstetrics and Gynecology175: 320–25. doi: 10.1016/S0002-9378(96)70141-2
31.
HuZ., ChengL., HuaX., and GlasierA.. 2005. Advanced provision of emergency contraception to postnatal women in China makes no difference in abortion rates: a randomized trial. Contraception72: 111–6. doi: 10.1016/j.contraception.2005.02.004
32.
JabbourH.N., and SalesK.J.. 2004. Prostaglandin receptor signalling and function in human endometrial pathology. Trends in Endocrinology and Metabolism15: 398–404. doi: 10.1016/S1043-2760(04)00187-0
33.
JesamC., SalvatierraA.M., SchwartzJ.L., and CroxattoH.B.. 2010. Suppression of follicular rupture with meloxicam, a cyclooxygenase-2 inhibitor: Potential for emergency contraception.Human Reproduction25: 368–73. doi: 10.1093/humrep/dep392
34.
John PaulPopeII. 1995. Encyclical letter The Gospel of Life Evangelium vitae. Boston, MA: Pauline Books.
35.
KellyR.W., KingA.E., and CritchleyH.O.D.. 2001. Cytokine control in human endometrium. Journals of Reproduction and Fertility121: 3–19. doi: 10.1530/rep.0.1210003
36.
Labcorp Corporation of America. 2012. Directory of services and interpretive guide: 2012–2015.
McCannN.C., LynchT.J., KimS.O., and DuffyD.M.. 2013. The COX-2 inhibitor meloxicam prevents pregnancy when administered as an emergency contraceptive to nonhuman primates. Contraception88: 744–8. doi: 10.1016/j.contraception.2013.09.006
39.
MendoncaL.L.F., KhamashtaM.A., Nelson-PierceyC., HuntB.J., and HughesG.R.V.. 2000. Non-steroidal anti-inflammatory drugs as a possible cause for reversible infertility. Rheumatology39: 880–82. doi: 10.1093/rheumatology/39.8.880
40.
MooreK. L., and PersaudT. V. N.. 2008. The beginning of human development: First week. InThe developing human: Clinically oriented embryology. 8th ed. Philadelphia: Saunders/Elsevier.
41.
MoynihanR.2009. Benedict and Barack: The little green book. Inside the Vatican17 (August–September): 10–15.
42.
MullerA.L., LladosC.M., and CroxattoH.B.. 2003. Postcoital treatment with levonorgestrel does not disrupt postfertilization events in the rat. Contraception67: 415–9. doi: 10.1016/S0010-7824(03)00021-0
43.
Nakhai-PourH.R., BroyP., SheehyO., and BerardA.. 2011. Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion. Canadian Medical Association Journal183: 1713–20. doi: 10.1503/cmaj.110454
44.
NoéG., CroxattoH.B., SalvatierraA.M., ReyesV., VillarroelC., MunozC., MoralesG., and RetamalesA.. 2010. Contraceptive efficacy of emergency contraception with levonorgestrel given before or after ovulation. Contraception81: 414–20. doi: 10.1016/j.contraception.2009.12.015
45.
NovikovaN., WeisbergE., StanczykF.Z., CroxattoH.B., and FraserI.S.. 2007. Effectiveness of levonorgestrel emergency contraception given before or after ovulation—A pilot study. Contraception75: 112–8. doi: 10.1016/j.contraception.2006.08.015
46.
OettelM., KomorA., GoncharovN.P., KurischkoA., StreckJ., and SchubertK.. 1980. STS 557 an interceptive in rodents and baboons. Contraception21: 537–45. doi: 10.1016/0010-7824(80)90017-7
47.
PeckR., and VelézJ.R.. 2013. The postovulatory mechanism of action of Plan B. National Catholic Bioethics Quarterly13 (4): 677–716. doi: 10.5840/ncbq201313410
48.
PepeG.J., and AlbrechtE.D.. 2003. Steroid endocrinology of pregnancy. InGynecology and obstetrics, ed. SciarraJohn J., 1–34. Philadelphia: Lippincott Williams & Wilkins.
PolisC.B., SchafferK., BlanchardK., GlasierA., HarperC.C., and GrimesD.A.. 2007. Advanced provision of emergency contraception for pregnancy prevention: A meta-analysis. Obstetrics and Gynecology110: 1379–88. doi: 10.1097/01.AOG.0000295603.84568.f6
52.
RavieleK.M.2014. Levonorgestrel in cases of rape: How does it work?Linacre Quarterly81: 117–29. doi: 10.1179/2050854914Y.0000000017
53.
RaymondE.G., TrussellJ., and PolisC.B.. 2007. Population effect of increased access to emergency contraceptive pills. Obstetrics and Gynecology109: 181–188. doi: 10.1097/01.AOG.0000250904.06923.4a
54.
ReznikS.E.2010. “Plan B:” How it works. Science shows it is not an abortifacient. Health Prog91(1). 1 (January–February): 59–61.
55.
Saint Joseph Hospital. 2007. Clinical laboratory services. Lexington, KY: Saint Joseph Hospital.
56.
SchneiderA.P.II, ZainerC.M., KubatC.K., MullenN.K., and WindischA.K.. 2014. The breast cancer epidemic: 10 facts. Linacre Quarterly81: 244–77.
57.
SinghM., ChaundhryP., and AsselinE.. 2011. Bridging endometrial receptivity and implantation: Network of hormones, cytokines, and growth factors. Journal of Endocrinology210: 5–14. doi: 10.1530/JOE-10-0461
58.
SperoffL., and DarneyP.. 2006. A clinical guide for contraception. 4th ed. Baltimore: William & Wilkins.
59.
StedmanT.L.2006. Stedman's medical dictionary. 28th ed. Philadelphia: Lippincott, Williams & Wilkins.
SunX., RuanY.C., GuoJ., ChenH., TsangL.L., ZhangX., JiangX., and ChanH.C.. 2014. Regulation of miR=101/miR-199a-3p by the epithelial sodium channel during embryo implantation: Involvement of CREB phosphorylation. Reproduction148: 559–568. doi: 10.1530/REP-14-0386
62.
Von HertzenH., PiaggioG., DingJ., ChenJ., SongS., BartfaiG., et al.of the WHO Task Force on Post-ovulatory Methods For Fertility Regulation—Special Programme. 2002. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: A WHO multicentre randomized trial. Lancet360: 1803–10. doi: 10.1016/S0140-6736(02)11767-3
63.
WilcoxA.J., WeinbergC.R., and BairdD.D.. 1998. Post-ovulatory ageing of the human oocyte and embryo failure. Human Reproduction13: 394–97. doi: 10.1093/humrep/13.2.394
64.
YegnanarayanR., and JoglekarG.V.. 1978. Anti-fertility effect of non-steroidal anti-inflammatory drugs. Japanese Journal of Pharmacology28: 909–17. doi: 10.1254/jjp.28.909
